Anti SLC6A2/NET polyclonal antibody
Code No: BMP029
Background:
SLC6A2, also known as NET, is a norepinephrine (noradrenaline) transporter, which regulates norepinephrine homeostasis by reuptaking the norepinephrine released into synaptic cleft in Na+- and Cl-- dependent manner. Mutation of the SLC6A2 gene can cause orthostatic intolerance, which is characterized by lightheadedness, fatigue, altered mental condition, and syncope. Drugs inhibiting the norepinephrine transporter such as antidepressants, cocaine, and amphetamines also lead to symptoms like orthostatic intolerance.
Product Type:
Primary Antibody
Species Reactivities:
Human
Related Products:
BMP029 anti-SLC6A2/NET (polyclonal)
BMP015 anti-SLC6A3/DAT1 (polyclonal)
BMP045 anti-SLC6A4/SERT (polyclonal)
BMP046 anti-SLC6A6/TAUT (polyclonal)
BMP016 anti-SLC6A7/PROT (polyclonal)
BMP047 anti-SLC6A8/CRTR (polyclonal)
BMP038 anti-SLC6A12/BGT-1 (polyclonal)
BMP051 anti-SLC6A13/GAT2 (polyclonal)
BMP052 anti-SLC6A14/ATB0+ (polyclonal)
BMP050 anti-SLC6A15/SBAT1 (polyclonal)
BMP053 anti-SLC6A19/B0AT1 (polyclonal)
References:
1) Kim, C. H., et al., PNAS 103, 19164-19169 (2006)
2) Paczkowski, F. A. et al., Pharmacogenetics 12, 165-173 (2002)
3) Shannon, J. R., et al., New Eng. J. Med. 342, 541-549 (2000)
4) Pacholczyk, T., et al., Nature 350, 350-354 (1991)
Formulation:
50 uL volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.
Reactivity:
This antibody can be used to stain endogenous antigen in paraffin embedded human tissues including brain and liver by Immunohistochemistry. The reactivity has been confirmed by Western blotting, Immunocytochemistry, and intracellular Flow cytometry to detect the full length of human SLC6A2 transiently expressed in HEK 293T cells.
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|